Transcend Therapeutics
Latest round
- Series A
Last raised
- Feb 2023
Total raised
- $40M
Investors
- 6
About Transcend Therapeutics
Based in New York, US, and founded in 2021 by Chairman Kevin Ryan, CEO Blake Mandell, and Chief Scientific Advisor Benjamin Kelmendi, Transcend Therapeutics, Inc. operates as a psychoactive medicine's provider for neuropsychiatric disease., a portfolio company of? AN Ventures acquired Transcend Therapeutics, Inc.2 billion. Transcend Therapeutics develops psychoactive drugs for patients suffering from post-traumatic stress disorder (PTSD) and depression. The company provides a compound known as TSND-201, which is medicine for short-acting and mild psychological treatment for PTSD. The firm serves industries such as biotechnology, Pharmacy, healthcare, and hospital.’s build its psychiatric services and solutions by integrating Transcend Therapeutics, Inc. capabilities.
Who invested in Transcend Therapeutics
6 investors across 2 rounds
See all investors in Transcend Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Transcend Therapeutics
Who invested in Transcend Therapeutics?
Transcend Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Transcend Therapeutics raised?
Transcend Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Transcend Therapeutics last raise money?
Transcend Therapeutics's most recent round on record is a Series A, in Feb 2023.
What does Transcend Therapeutics do?
Based in New York, US, and founded in 2021 by Chairman Kevin Ryan, CEO Blake Mandell, and Chief Scientific Advisor Benjamin Kelmendi, Transcend Therapeutics, Inc.
Where is Transcend Therapeutics headquartered?
Transcend Therapeutics is headquartered in New York, US.
Which VCs invest in companies like Transcend Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Transcend Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Transcend Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.